Specificity of HercepTest in Determining <i>HER-2</i>/<i>neu</i> Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System

Timothy W. Jacobs(Harvard University), Stuart J. Schnitt(Beth Israel Deaconess Medical Center)
Journal of Clinical Oncology
July 1, 1999
Cited by 459


Related Papers